October, 2024
October 2024
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Stephen V Liu: Real-world 5-year survival with first line pembrolizumab in PD-L1 high NSCLC
Oct 29, 2024, 10:11

Stephen V Liu: Real-world 5-year survival with first line pembrolizumab in PD-L1 high NSCLC

Stephen V Liu, Associate Professor of Medicine at Georgetown University, shared a post on X:

Real-world 5-year survival with 1L pembrolizumab in PD-L1 high NSCLC in current issue of Clinical Lung Cancer. With median f/u 60.5m, OS 19.2m, 5y OS rate 25.1%. Also noted 33% received subsequent therapy.”

5-Year Real-World Outcomes With Frontline Pembrolizumab Monotherapy in PD-L1 Expression ≥ 50% Advanced NSCLC

Authors: Vamsidhar Velcheti, Pragya Rai, Yu-Han Kao, Diana Chirovsky, Ana Tablante Nunes and Stephen V. Liu.

Stephen V Liu

Luis E. Raez shared the above post on X, adding:

“We learn that 25% of our pdl-1 high patients can live more than 5 years compare with 5% we use to get with chemo alone before there is progress, more needs to be done.”

Stephen V Liu is an Associate Professor of Medicine at Georgetown University, where he holds the positions of Director of Thoracic Oncology and Head of Developmental Therapeutics at the Georgetown Lombardi Comprehensive Cancer Center. As a board-certified medical oncologist specializing in lung cancer and drug development, Dr. Liu is known for his expertise in advanced thoracic malignancies.

His research focuses on novel therapeutic agents and innovative combinations to improve treatment outcomes for patients with lung cancer. Dr. Liu has received multiple teaching awards and actively engages in post-graduate education initiatives. Furthermore, he co-hosts the official podcast of the International Association for the Study of Lung Cancer (IASLC), “Lung Cancer Considered”.

Dr. Luis E. Raez is the Medical Director and Chief Scientific Officer at Memorial Cancer Institute, part of Memorial Healthcare System. He specializes in treating lung and head and neck cancers and leads the Thoracic Oncology Program as Director. Dr. Raez is also a clinical professor of medicine at Florida International University (FIU), a research professor at Florida Atlantic University (FAU), and a visiting professor of medicine at Cayetano Heredia University (UPCH) in Peru.